1,645
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 44-48 | Received 30 Jun 2021, Accepted 13 Sep 2021, Published online: 23 Dec 2021

References

  • Sunkara SK, La Marca A, Polyzos NP, et al. Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of nationwide data. Hum Reprod. 2016;31(10):2261–2267.
  • Fauser BCJM, Evian Annual Reproduction Workshop Group 2007, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14(1):1–4.
  • Nardo LG, Fleming R, Howles CM, et al. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online. 2011;23(2):141–148.
  • Shpakov AO. Gonadotropins – from theory to clinical practice. SPb.: POLITEХ. 2018;347.
  • Bousfield GR, Butnev VY, Hiromasa Y, et al. Hypo-glycosylated human follicle-stimulating hormone (hFSH(21/18)) is much more active in vitro than fully-glycosylated hFSH (hFSH(24)). Mol Cell Endocrinol. 2014;382(2):989–997.
  • Casarini L, Lispi M, Longobardi S, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLos One. 2012;7(10):e46682.
  • Riccetti L, De Pascali F, Gilioli L, et al. Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro. Reprod Biol Endocrinol. 2017;15(1):2.
  • Riccetti L, Yvinec R, Klett D, et al. Human luteinizing hormone and chorionic gonadotropin display biased agonism at the LH and LH/CG receptors. Sci. Rep. 2017;7(1):940.
  • Casarini L, La Marca A, Lispi M, et al. Non-equivalence of LH and hCG: an vitro study//Proc. The 27th Annual Meeting of the European Society Of Human Reproduction & Embryology, 3-6 July 2011, Stockholm, Sweden. 2011. P. p. 312.
  • Casarini L, Riccetti L, De Pascali F, et al. Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro. Mol Cell Endocrinol. 2016;422:103–114.
  • Hershko Klement A, Shulman A. hCG triggering in ART: an evolutionary concept. IJMS. 2017;18(5):1075.
  • Youssef MA, Abou-Setta AM, Lam WS. S. Recombinant versus urinary human chorionic gonadotropin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev. 2016;4:CD003719.
  • Levi-Setti PE, Zerbetto I, Baggiani A, et al. An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria. Front Endocrinol (Lausanne)). 2019;10:282.
  • Polyzos NP, Camus M, Llacer J, et al. Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of multicentre randomized trial. BMJ Open. 2013;3(6):e002938.